Showing results (111-120 of 145) with videos related to

Sort By:
Pageof 15
Lancet (London, England)|September 22, 2023
Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trialAkimichi Morita, Bruce Strober, A David Burden, et al.
BMJ Open|March 31, 2021
Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flareSiew Eng Choon, Mark G Lebwohl, Slaheddine Marrakchi, et al.
The American Journal of Pathology|August 8, 2012
Elevated expression of the chemokine-scavenging receptor D6 is associated with impaired lesion development in psoriasisMark D Singh, Vicky King, Helen Baldwin, et al.
American Journal of Human Genetics|August 16, 2011
Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasisAlexandros Onoufriadis, Michael A Simpson, Andrew E Pink, et al.
The Journal of Investigative Dermatology|August 22, 2018
Defining the Therapeutic Range for Adalimumab and Predicting Response in Psoriasis: A Multicenter Prospective Observational Cohort StudyNina Wilkinson, Teresa Tsakok, Nick Dand, et al.
The Journal of Investigative Dermatology|May 2, 2017
Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-AnalysisZarif K Jabbar-Lopez, Zenas Z N Yiu, Victoria Ward, et al.
The Journal of Investigative Dermatology|September 21, 2019
IL-36 Promotes Systemic IFN-I Responses in Severe Forms of PsoriasisMarika Catapano, Marta Vergnano, Marco Romano, et al.
The Journal of Investigative Dermatology|June 9, 2015
Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)Richard B Warren, Catherine H Smith, Zenas Z N Yiu, et al.
The New England Journal of Medicine|December 22, 2021
Trial of Spesolimab for Generalized Pustular PsoriasisHervé Bachelez, Siew-Eng Choon, Slaheddine Marrakchi, et al.
The Journal of Investigative Dermatology|April 18, 2016
Risk of Serious Infections in Patients with Psoriasis on Biologic Therapies: A Systematic Review and Meta-AnalysisZenas Z N Yiu, Lesley S Exton, Zarif Jabbar-Lopez, et al.
Pageof 15